Evidence map›Paper›PMID 42712499›Full record

ArticleFrontiers in epidemiology2026

Last mile at the center of immunization delivery.

Grace Umutesi, Sara Rendell, Ruanne V Barnabas

Abstract read
In one paragraph

Article in Frontiers in epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Grace Umutesi *Department of Global Health, University of Washington, Seattle, WA, United States.
Sara Rendell *Division of Infectious Diseases, Mass General Brigham, Boston, MA, United States.
Ruanne V BarnabasDivision of Infectious Diseases, Mass General Brigham, Boston, MA, United States.

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI007433
6 · The paper itself

Abstract

While advances in immunization led to major reductions in vaccine-preventable diseases in the past four decades, large gaps remain in the delivery of immunization services. In this perspective, we use illustrative examples to discuss gaps in global immunization and outline opportunities for evidence generation and intervention design to transform the last mile delivery of immunization services in global health. To address last mile gaps, technical limitations in global health surveillance infrastructure that result in imprecise estimates and overlapping obstacles that complicate immunization service delivery for selected groups need to be addressed. Additionally, leveraging pro-equity strategies from the community level to the global level and across phases of translational health research could accelerate the equitable impact of immunization innovations on population health outcomes.

Indexed as

equityglobal healthimmunizationlast mile deliveryvaccine-preventable diseases

Identifiers

PMID42712499
PMCPMC13550154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.